Metraipolis › archive › dc_e7ed955dff0a
Predictive Role of Serum Inflammatory Markers in Metastatic Luminal A/B Breast Cancers Receiving CDK-4/6 Inhibitors Therapy — Europe PMC PMID:42021467
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42021467
- DOI
- 10.1002/iid3.70442
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T13:25:37.420Z
- SHA-256 of the archived text
ffd149179af5a7caa1f766e68408f44547af5b2fe669f5908329886005b8641e- Stable URL of this page
https://metraipolis.com/documento/dc_e7ed955dff0a
How to cite
Predictive Role of Serum Inflammatory Markers in Metastatic Luminal A/B Breast Cancers Receiving CDK-4/6 Inhibitors Therapy — Europe PMC PMID:42021467 — Europe PMC (en), https://europepmc.org/article/MED/42021467 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e7ed955dff0a (Metraipolis archive dc_e7ed955dff0a, sha256 ffd149179af5a7caa1f766e68408f44547af5b2fe669f5908329886005b8641e)
BibTeX
@misc{dce7ed955dff0a,
title = {Predictive Role of Serum Inflammatory Markers in Metastatic Luminal A/B Breast Cancers Receiving CDK-4/6 Inhibitors Therapy — Europe PMC PMID:42021467},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42021467},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e7ed955dff0a; sha256 ffd149179af5a7caa1f766e68408f44547af5b2fe669f5908329886005b8641e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42021467. Agents can read the archived copy with the MCP tool read_document.